Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update
By Y. Liaw, J. Kao, T. Piratvisuth, H. Chan, R. Chien, Chun-Jen Liu, E. Gane, S. Locarnini, S. Lim, K. Han and 10 more. Hepatology International, 2012
1,079 citations recorded by the source corpus.
Subfields: Epidemiology, Hepatology
View Paper: https://www.semanticscholar.org/paper/1ee485c571d0a45f06337a240bb7e1a9302808b4
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Epidemiology
In Hepatology
Citations in the corpus
- Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update (2015, background): “59 ULN; as minimally raised serum ALT if between ULN and 29 ULN of ALT level; and as raised ALT if[29 ULN [19].”
- EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis. (2015, background): “According to all regional guidelines, patients with liver cirrhosis and significant viraemia (HBV DNA >2000 IU/ml) should receive antiviral treatment regardless of the ALT levels [251–253].”